🔎 Trials Near Me

Gara Jalqabaatti › Lymphoma › Utah

Qorannoo klinikaalii Lymphoma Utah keessatti

Qorannoo 14 Lymphoma f Utah keessatti hirmaatuu jiru.

Magaalota Utah keessatti

Takkalaa qorannoo (Ingiliffa)

T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)

  • Intermountain Health, Canyons Region, LDS Hospital, Salt Lake City
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06343311

A Resilience-Based Approach to Improve Long-term Quality of Life in Post-treatment Lymphoma Survivorship

  • Huntsman Cancer Institute, Salt Lake City
Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07013435

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

  • University of Utah, Salt Lake City
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT07221500

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

  • Primary Children's Hospital, Salt Lake City
Namoota walitti qabaa jiraSadarkaa 1/2
12 Months – 21 Years · Saalaa hunda · Haaromfame 11-Ful-2026 · NCT04870944

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

  • Huntsman Cancer Institute, Salt Lake City
  • Intermountain Healthcare, Salt Lake City
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 25-Hag-2026 · NCT05826535

A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer

  • START Mountain Region, West Valley City
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 20-Hag-2026 · NCT06678659

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

  • Intermountain Healthcare, Salt Lake City
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Hag-2026 · NCT07188558

Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

  • Huntsman Cancer Institute, University of Utah, Salt Lake City
Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Wax-2026 · NCT05663502

Safety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With Relapsed or Refractory Lymphomas and Solid Tumors

  • START Mountain Region, West Valley City
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 04-Cam-2026 · NCT06132503

Trial to Evaluate the Safety & Tolerability of JBZ-001 in Pts With Advanced Solid and Hematological Malignancies

  • START Mountain Region, West Valley City
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Elb-2026 · NCT06801002

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

  • Huntsman Cancer Institute, University of Utah, Salt Lake City
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 16-Elb-2026 · NCT03328078

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

  • Huntsman Cancer Institute, University of Utah, Salt Lake City
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Bit-2026 · NCT04830137

Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell Immunotherapy

  • Huntsman Cancer Institute at University of Utah, Salt Lake City
Namoota walitti qabaa jira
Umuriin 21 fi ol · Saalaa hunda · Haaromfame 05-Gur-2026 · NCT07390071

A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies

  • University of Utah, Salt Lake City
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Sad-2025 · NCT05643742

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.